company background image
2728 logo

Teyi Pharmaceutical GroupLtd SZSE:002728 Stock Report

Last Price

CN¥8.35

Market Cap

CN¥4.3b

7D

4.0%

1Y

-27.4%

Updated

13 Jun, 2024

Data

Company Financials +

Teyi Pharmaceutical Group Co.,Ltd

SZSE:002728 Stock Report

Market Cap: CN¥4.3b

2728 Stock Overview

Engages in the research and development, production, and sale of proprietary Chinese medicines, chemical preparations, raw materials, and products in the People’s Republic of China.

2728 fundamental analysis
Snowflake Score
Valuation3/6
Future Growth4/6
Past Performance2/6
Financial Health6/6
Dividends2/6

Teyi Pharmaceutical Group Co.,Ltd Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Teyi Pharmaceutical GroupLtd
Historical stock prices
Current Share PriceCN¥8.35
52 Week HighCN¥17.49
52 Week LowCN¥7.98
Beta1.61
1 Month Change-14.53%
3 Month Change-27.62%
1 Year Change-27.39%
3 Year Change18.34%
5 Year Change-1.17%
Change since IPO62.36%

Recent News & Updates

We Think Teyi Pharmaceutical GroupLtd (SZSE:002728) Can Stay On Top Of Its Debt

Jun 06
We Think Teyi Pharmaceutical GroupLtd (SZSE:002728) Can Stay On Top Of Its Debt

Why Teyi Pharmaceutical GroupLtd's (SZSE:002728) Shaky Earnings Are Just The Beginning Of Its Problems

Apr 26
Why Teyi Pharmaceutical GroupLtd's (SZSE:002728) Shaky Earnings Are Just The Beginning Of Its Problems

Recent updates

We Think Teyi Pharmaceutical GroupLtd (SZSE:002728) Can Stay On Top Of Its Debt

Jun 06
We Think Teyi Pharmaceutical GroupLtd (SZSE:002728) Can Stay On Top Of Its Debt

Why Teyi Pharmaceutical GroupLtd's (SZSE:002728) Shaky Earnings Are Just The Beginning Of Its Problems

Apr 26
Why Teyi Pharmaceutical GroupLtd's (SZSE:002728) Shaky Earnings Are Just The Beginning Of Its Problems

Teyi Pharmaceutical Group Co.,Ltd's (SZSE:002728) Shares Bounce 29% But Its Business Still Trails The Market

Mar 06
Teyi Pharmaceutical Group Co.,Ltd's (SZSE:002728) Shares Bounce 29% But Its Business Still Trails The Market

Here's Why We Think Teyi Pharmaceutical GroupLtd (SZSE:002728) Is Well Worth Watching

Feb 27
Here's Why We Think Teyi Pharmaceutical GroupLtd (SZSE:002728) Is Well Worth Watching

Shareholder Returns

2728CN PharmaceuticalsCN Market
7D4.0%-0.8%-0.9%
1Y-27.4%-9.9%-14.4%

Return vs Industry: 002728 underperformed the CN Pharmaceuticals industry which returned -9.9% over the past year.

Return vs Market: 002728 underperformed the CN Market which returned -14.4% over the past year.

Price Volatility

Is 2728's price volatile compared to industry and market?
2728 volatility
2728 Average Weekly Movement5.9%
Pharmaceuticals Industry Average Movement5.5%
Market Average Movement6.7%
10% most volatile stocks in CN Market10.1%
10% least volatile stocks in CN Market4.1%

Stable Share Price: 002728's share price has been volatile over the past 3 months.

Volatility Over Time: 002728's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20021,243n/awww.tczy.com.cn

Teyi Pharmaceutical Group Co.,Ltd engages in the research and development, production, and sale of proprietary Chinese medicines, chemical preparations, raw materials, and products in the People’s Republic of China. The company offers cough and phlegm, kidney, anti- infection, cardiovascular and cerebrovascular, and digestive system drugs. Its chemical raw materials and products include aluminum magnesium carbonate, phenytoin, ferrous sulfate, glacial acetic acid, calcium chloride, sodium chloride, bismuth series, citric acid series, zinc sulfate, etc. The company was formerly known as Guangdong Taicheng Pharmaceutical Co., Ltd.

Teyi Pharmaceutical Group Co.,Ltd Fundamentals Summary

How do Teyi Pharmaceutical GroupLtd's earnings and revenue compare to its market cap?
2728 fundamental statistics
Market capCN¥4.31b
Earnings (TTM)CN¥156.86m
Revenue (TTM)CN¥927.67m

27.2x

P/E Ratio

4.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
2728 income statement (TTM)
RevenueCN¥927.67m
Cost of RevenueCN¥446.64m
Gross ProfitCN¥481.03m
Other ExpensesCN¥324.17m
EarningsCN¥156.86m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.31
Gross Margin51.85%
Net Profit Margin16.91%
Debt/Equity Ratio14.7%

How did 2728 perform over the long term?

See historical performance and comparison

Dividends

4.3%

Current Dividend Yield

104%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.